InvestorsHub Logo
Followers 120
Posts 20759
Boards Moderated 0
Alias Born 06/13/2011

Re: None

Saturday, 06/01/2019 10:40:27 PM

Saturday, June 01, 2019 10:40:27 PM

Post# of 426561
Well if we aren't going to die from strokes or heart attacks because we're on Vascepa ....the next thing is wether we'll develop Alzheimer or not

https://nutritionj.biomedcentral.com/articles/10.1186/1475-2891-13-112.

"Conclusions

Serum EPA concentration is associated with cognitive function in patients with CAD, suggesting that a low serum EPA level is a risk factor for cognitive impairment independent of cardiac function, including left ventricular ejection fraction."

Imagine if a year after we have sold ourselves to a BP , we find that Vascepa does indeed lower the risk of developing Alzheimer .
Hmmmm!
Kiwi

note "Therefore, one possible mechanism is that decreased EPA results in microcirculation insufficiency in the brain, thus leading to ischemia-induced brain damage. It has been reported that EPA enhances endothelial expression of nitric oxide synthase, and activation of endothelial nitric oxide synthase leads to vasodilation and endothelial protection ".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News